Project Category : Cardiovascular

LATEST INDUSTRY PROJECTS IN CARDIOVASCULAR

Wilate, von Willebrand Factor/Coagulation Factor Concentrate
Wilate is a von Willebrand Factor/Coagulation Factor VIII (vWF/FVIII)...

Edoxaban, Oral Anticoagulant
Edoxaban is an oral anticoagulant currently under development...

Revatio (Sildenafil) - Treatment for Pulmonary Arterial Hypertension
Revatio is an approved formulation developed by Pfizer for the...

AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia
Under development by Amarin Corporation, AMR101 is a partially...

Kalbitor - Treatment for Hereditary Angioedema
Kalbitor (ecallantide) is a drug developed by US-based Dyax Corp...

BNC105
BNC105, being developed by Adelaide-based Bionomics, is a new...

AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia, United Kingdom
BNC105 – Vascular Targeting Agent for Cancer Treatment,
Darapladib - Selective Lp-PLA2 Inhibitor for Prevention of Atherosclerosis,
Edoxaban, Oral Anticoagulant, Japan
ETC-216 - Phospholipid Therapy for Coronary Heart Disease (CHD) Patients,
Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism,
Kalbitor - Treatment for Hereditary Angioedema,
Lipitor / Torcetrapib - Combination Therapy for the Management of Dyslipidaemia,
Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia,
Pradaxa – Oral Direct Thrombin Inhibitor,
Prasugrel - Investigational Antiplatelet Agent,
Rasilez – Innovative Treatment for Hypertension,
Revatio (Sildenafil) - Treatment for Pulmonary Arterial Hypertension, USA
TRA-SCH-530348 -Oral Antiplatelet Agent,
Wilate, von Willebrand Factor/Coagulation Factor Concentrate, Switzerland